warfarin has been researched along with Coronary-Vessel-Anomalies* in 3 studies
3 other study(ies) available for warfarin and Coronary-Vessel-Anomalies
Article | Year |
---|---|
Transcatheter closure of congenital coronary arteriovenous fistula using detachable balloon technique.
Topics: Angioplasty, Balloon, Coronary; Anticoagulants; Arteriovenous Fistula; Aspirin; Child, Preschool; Coronary Vessel Anomalies; Equipment Design; Fibrinolytic Agents; Heart Murmurs; Humans; Male; Treatment Outcome; Warfarin | 2010 |
[Thrombosed giant proximal pulmonary artery aneurysm].
We present a 36-year-old male patient with a previous diagnosis (22 years) of Eisenmenger's syndrome, who had a giant proximal pulmonary artery aneurysm complicated by massive thrombus formation. The patient experienced paroxysmal atrial fibrillation attacks for the past month. His functional capacity was New York Heart Association class III. Chest radiography showed aneurysmal dilatation in the left pulmonary artery. The patient was assessed by transthoracic echocardiography and multislice computed tomography. There was mild narrowing in the thick and calcified pulmonary valve (peak systolic gradient 35 mmHg) and moderate regurgitation. The mean pulmonary artery pressure was estimated as 50 mmHg. The diameters of the main, left, and right pulmonary arteries were 6.5 cm, 10 cm, and 3.7 cm, respectively. There was a massive thrombus in the aneurysmatic left pulmonary artery. The patient was referred to the cardiovascular surgery department for pulmonary artery reconstruction and cardiopulmonary transplantation. In addition, medical treatment was instituted with warfarin for thrombus and paroxysmal atrial fibrillation, metoprolol for atrial fibrillation, and bosentan for pulmonary hypertension. The patient's functional capacity showed improvement after the first month of medical treatment and no complications were seen within a year follow-up. Topics: Anti-Arrhythmia Agents; Anticoagulants; Atrial Fibrillation; Calcinosis; Child; Coronary Vessel Anomalies; Eisenmenger Complex; Humans; Male; Metoprolol; Pulmonary Embolism; Radiography, Thoracic; Tomography, X-Ray Computed; Treatment Outcome; Warfarin | 2009 |
Acute myocardial infarction in a patient with anomalous left coronary artery origin and primary antiphospholipid syndrome.
Anomalous left main coronary artery (LMCA) originating from the right coronary sinus and running between the aorta and pulmonary trunk is a rare congenital condition. Although this disease is known to be associated with myocardial infarction and sudden death, the precise mechanism is uncertain. A 14-year-old male with this anomaly developed myocardial infarction during exercise complicated by primary antiphospholipid syndrome. He was admitted to hospital with persistent chest pain and sudden cardiac collapse that occurred while he was running. Cardiac catheterization demonstrated a narrowed segment in the LMCA and impaired blood flow, prompting a diagnosis of extensive anterior myocardial infarction. Emergency bypass surgery was performed using a single saphenous vein graft to the left anterior descending artery. Postoperative angiography showed the presence of an anomalous LMCA arising from the right sinus of Valsalva and running between the great vessels. The aortic samples were pathologically normal. He was discovered to also have primary antiphospholipid syndrome and was discharged without symptoms after warfarin therapy. Complicated primary antiphospholipid syndrome may trigger myocardial infarction in asymptomatic patients with this type of coronary anomaly. Topics: Acute Disease; Adolescent; Anticoagulants; Antiphospholipid Syndrome; Coronary Artery Bypass; Coronary Vessel Anomalies; Humans; Male; Myocardial Infarction; Warfarin | 2000 |